Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
- PMID: 24105274
- DOI: 10.1038/nrg3554
Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer
Abstract
Malignancies are characterized by extensive global reprogramming of epigenetic patterns, including gains or losses in DNA methylation and changes to histone marks. Furthermore, high-resolution genome-sequencing efforts have discovered a wealth of mutations in genes encoding epigenetic regulators that have roles as 'writers', 'readers' or 'editors' of DNA methylation and/or chromatin states. In this Review, we discuss how these mutations have the potential to deregulate hundreds of targeted genes genome wide. Elucidating these networks of epigenetic factors will provide mechanistic understanding of the interplay between genetic and epigenetic alterations, and will inform novel therapeutic strategies.
Similar articles
-
Gain-of-function mutation of chromatin regulators as a tumorigenic mechanism and an opportunity for therapeutic intervention.Curr Opin Oncol. 2015 Jan;27(1):57-63. doi: 10.1097/CCO.0000000000000151. Curr Opin Oncol. 2015. PMID: 25402979 Free PMC article. Review.
-
Therapeutic targeting of chromatin: status and opportunities.FEBS J. 2022 Mar;289(5):1276-1301. doi: 10.1111/febs.15966. Epub 2021 Jun 25. FEBS J. 2022. PMID: 33982887 Review.
-
The roles of DNA, RNA and histone methylation in ageing and cancer.Nat Rev Mol Cell Biol. 2019 Oct;20(10):573-589. doi: 10.1038/s41580-019-0143-1. Epub 2019 Jul 3. Nat Rev Mol Cell Biol. 2019. PMID: 31270442 Review.
-
Driver mutations of cancer epigenomes.Protein Cell. 2014 Apr;5(4):265-96. doi: 10.1007/s13238-014-0031-6. Epub 2014 Mar 14. Protein Cell. 2014. PMID: 24622842 Free PMC article.
-
Chromatin regulators with tumor suppressor properties and their alterations in human cancers.Epigenomics. 2012 Oct;4(5):537-49. doi: 10.2217/epi.12.50. Epigenomics. 2012. PMID: 23130835 Review.
Cited by
-
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer.Oncotarget. 2015 Feb 10;6(4):2466-82. doi: 10.18632/oncotarget.2967. Oncotarget. 2015. PMID: 25537518 Free PMC article.
-
Depletion of Histone Demethylase Jarid1A Resulting in Histone Hyperacetylation and Radiation Sensitivity Does Not Affect DNA Double-Strand Break Repair.PLoS One. 2016 Jun 2;11(6):e0156599. doi: 10.1371/journal.pone.0156599. eCollection 2016. PLoS One. 2016. PMID: 27253695 Free PMC article.
-
Generalized nucleation and looping model for epigenetic memory of histone modifications.Proc Natl Acad Sci U S A. 2016 Jul 19;113(29):E4180-9. doi: 10.1073/pnas.1605862113. Epub 2016 Jul 5. Proc Natl Acad Sci U S A. 2016. PMID: 27382173 Free PMC article.
-
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.Nat Genet. 2018 Oct;50(10):1399-1411. doi: 10.1038/s41588-018-0209-6. Epub 2018 Sep 27. Nat Genet. 2018. PMID: 30262818 Free PMC article.
-
Silencing of CHFR Sensitizes Gastric Carcinoma to PARP Inhibitor Treatment.Transl Oncol. 2020 Jan;13(1):113-121. doi: 10.1016/j.tranon.2019.10.004. Epub 2019 Dec 4. Transl Oncol. 2020. PMID: 31812083 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources